Once-daily vs. twice-daily dosing of enoxaparin for the management of venous thromboembolism: A systematic review and meta-analysis

The present study aimed to determine whether there is any difference in the efficacy and safety of once-daily vs. twice-daily enoxaparin when used for the initial treatment of venous thromboembolism (VTE). The PubMed, Embase, Cochrane Central Register of Controlled Trials, Science Direct and Google...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Jingrong, Song, Yixiao, Li, Chunmin, Ren, Hualiang, Zhang, Wangde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444420/
https://www.ncbi.nlm.nih.gov/pubmed/32855676
http://dx.doi.org/10.3892/etm.2020.9036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444420/
https://www.ncbi.nlm.nih.gov/pubmed/32855676
http://dx.doi.org/10.3892/etm.2020.9036

Ejemplares similares